Severe hypocalcaemia after being given intravenous bisphosphonate.
作者信息
Peter Rajesh, Mishra Vinita, Fraser William D
机构信息
Department of Clinical Chemistry, Royal Liverpool University Hospital, Liverpool L69 3GA.
出版信息
BMJ. 2004 Feb 7;328(7435):335-6. doi: 10.1136/bmj.328.7435.335.
Abstract
摘要
相似文献
1
Severe hypocalcaemia after being given intravenous bisphosphonate.静脉注射双膦酸盐后出现严重低钙血症。
BMJ. 2004 Feb 7;328(7435):335-6. doi: 10.1136/bmj.328.7435.335.
2
3
Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastases.唑来膦酸诱发一名雄激素非依赖性前列腺癌伴广泛骨转移患者出现持续性低钙血症。
Clin Genitourin Cancer. 2007 Sep;5(6):403-5. doi: 10.3816/CGC.2007.n.025.
4
Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.多发性骨髓瘤患者接受双膦酸盐治疗相关的症状性低钙血症和肾功能损害。
Intern Med J. 2005 Dec;35(12):726-8. doi: 10.1111/j.1445-5994.2005.00949.x.
5
Short-term safety assessment in the use of intravenous zoledronic acid in children.儿童静脉注射唑来膦酸使用的短期安全性评估
J Pediatr. 2004 Nov;145(5):701-4. doi: 10.1016/j.jpeds.2004.06.066.
6
Hypocalcaemia after intravenous bisphosphonate: read the product information first.静脉注射双膦酸盐后出现低钙血症：请先阅读产品说明书。
BMJ. 2004 Jun 12;328(7453):1439; author reply 1439-40. doi: 10.1136/bmj.328.7453.1439.
7
Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature.双膦酸盐诱发的低钙血症——6例报告及文献综述
Swiss Med Wkly. 2014 Jun 25;144:w13979. doi: 10.4414/smw.2014.13979. eCollection 2014.
8
Zoledronic acid.唑来膦酸
Drugs. 2001;61(6):799-805; discussion 806. doi: 10.2165/00003495-200161060-00010.
9
By the way, doctor. Should I take an intravenous drug for osteoporosis?顺便问一下，医生。我应该通过静脉注射药物来治疗骨质疏松症吗？
Harv Womens Health Watch. 2007 Jul;14(11):8.
10
Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration.
J Palliat Med. 2007 Dec;10(6):1226-7. doi: 10.1089/jpm.2007.0113.
引用本文的文献
1
FGF23-secreting sinonasal tumour presenting with acute subdural haemorrhage and tumour-induced osteomalacia.分泌成纤维细胞生长因子 23 的鼻腔鼻窦肿瘤表现为急性硬脑膜下血肿和肿瘤相关性骨软化症。
BMJ Case Rep. 2024 Aug 8;17(8):e259439. doi: 10.1136/bcr-2023-259439.
2
Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).骨 Paget 病的诊断和治疗：意大利骨质疏松症、矿物质代谢和骨骼疾病学会（SIOMMMS）立场文件。
J Endocrinol Invest. 2024 Jun;47(6):1335-1360. doi: 10.1007/s40618-024-02318-1. Epub 2024 Mar 15.
3
Case Report and Literature Review: Bisphosphonate, Sirolimus, and Atenolol Treatment in a 4-Year-Old Child Diagnosed with Gorham-Stout Disease.病例报告与文献综述：一名4岁戈谢病患儿接受双膦酸盐、西罗莫司和阿替洛尔治疗
Pharmaceuticals (Basel). 2023 Oct 23;16(10):1504. doi: 10.3390/ph16101504.
4
Impact of Osteoporosis Pharmacotherapy on Functional Outcomes after Ischemic Stroke.骨质疏松症药物治疗对缺血性中风后功能结局的影响
J Clin Med. 2023 Jul 26;12(15):4905. doi: 10.3390/jcm12154905.
5
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw.前列腺癌患者的骨靶向药物：一般毒性与颌骨坏死
Curr Oncol. 2022 Mar 5;29(3):1709-1722. doi: 10.3390/curroncol29030142.
6
Elevated parathyroid hormone levels in older women treated for osteoporosis using denosumab.接受地舒单抗治疗骨质疏松症的老年女性甲状旁腺激素水平升高。
Eur Geriatr Med. 2022 Jun;13(3):735-740. doi: 10.1007/s41999-021-00567-4. Epub 2021 Sep 29.
7
Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways.款冬酮通过抑制NF-κB和P38丝裂原活化蛋白激酶信号通路抑制破骨细胞生成和假体周围骨溶解。
Front Pharmacol. 2020 Apr 3;11:385. doi: 10.3389/fphar.2020.00385. eCollection 2020.
8
Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report.唑来膦酸治疗骨质疏松症相关的症状性低钙血症：一例报告
Oman Med J. 2013 Mar;28(2):e043. doi: 10.5001/omj.2013.42.
9
Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database.在一个商业健康计划数据库中，诊断代码对于识别绝经后骨质疏松症女性严重低钙血症和皮肤不良事件的预测价值。
BMC Health Serv Res. 2018 Apr 10;18(1):263. doi: 10.1186/s12913-018-3016-y.
10
Effect of bisphosphonate initiation at week 2 versus week 12 on short-term functional recovery after femoral neck fracture: a randomized controlled trial.第2周与第12周开始使用双膦酸盐对股骨颈骨折后短期功能恢复的影响：一项随机对照试验。
Arch Osteoporos. 2017 Dec;12(1):27. doi: 10.1007/s11657-017-0321-8. Epub 2017 Mar 10.
本文引用的文献
1
2
Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.帕米膦酸二钠给药后出现的持续性、症状性低钙血症及亚临床甲状旁腺功能减退。
Endocrine. 2001 Mar;14(2):159-64. doi: 10.1385/ENDO:14:2:159.
3
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.唑来膦酸在治疗恶性肿瘤高钙血症方面优于帕米膦酸：两项随机对照临床试验的汇总分析。
J Clin Oncol. 2001 Jan 15;19(2):558-67. doi: 10.1200/JCO.2001.19.2.558.
4
Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
Clin Oncol (R Coll Radiol). 1998;10(6):407-9. doi: 10.1016/s0936-6555(98)80045-9.
5
Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate.一名患有潜在甲状旁腺功能减退症和乳腺癌伴骨转移的患者在使用帕米膦酸盐后出现症状性低钙血症。
Intern Med. 1998 Apr;37(4):396-7. doi: 10.2169/internalmedicine.37.396.
6
Symptomatic hypocalcemia after intravenous pamidronate.静脉注射帕米膦酸盐后出现症状性低钙血症。
J Palliat Care. 1996 Spring;12(1):46-7.
7
Safety of pamidronate in patients with renal failure and hypercalcemia.
Clin Nephrol. 1996 Mar;45(3):175-9.
8
Metabolic effects of pamidronate in patients with metastatic bone disease.帕米膦酸对转移性骨病患者的代谢影响。
Br J Cancer. 1996 May;73(9):1089-95. doi: 10.1038/bjc.1996.210.
9
Rehydration in the treatment of severe hypercalcaemia.
Q J Med. 1981 Autumn;50(200):473-81.
10
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.
Am J Med. 1987 Jun;82(6):1133-42. doi: 10.1016/0002-9343(87)90215-4.
Zotero 插件